Detalles de la búsqueda
1.
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial.
Blood;
138(23): 2337-2346, 2021 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320162
2.
Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.
Haematologica;
108(8): 2044-2058, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815378
3.
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Pediatr Blood Cancer;
70(5): e30251, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36789545
4.
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer;
69(1): e29313, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34472213
5.
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Cancer Causes Control;
32(3): 241-250, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392905
6.
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Blood;
132(15): 1584-1592, 2018 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30150206
7.
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.
Haematologica;
105(7): 1879-1886, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32029509
8.
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC).
Genet Med;
21(9): 1903-1916, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138931
9.
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.
Blood;
129(25): 3304-3313, 2017 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28389462
10.
Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.
Blood;
129(23): 3051-3058, 2017 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28411282
11.
Factors predicting early mortality after new diagnosis of myelodysplastic syndrome: A population-based study.
Eur J Haematol;
103(1): 56-63, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31058390
12.
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
Pediatr Blood Cancer;
65(7): e27034, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29528181
13.
Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Int J Cancer;
140(1): 23-33, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27603749
14.
Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.
Haematologica;
102(12): 2058-2068, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28883080
15.
Chimerism for 20q11.2 microdeletion of GDF5 explains discordant phenotypes in monochorionic-diamniotic twins.
Am J Med Genet A;
173(12): 3182-3188, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28884893
16.
Ph-like gene alterations and complex chromosomal abnormalities are frequent in patients with acute lymphoblastic leukemia experiencing relapse after allogeneic hematopoietic cell transplantation.
Eur J Haematol;
109(4): 406-408, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35700331
17.
Association between mitochondrial DNA haplogroup and myelodysplastic syndromes.
Genes Chromosomes Cancer;
55(9): 688-93, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27121678
18.
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
Blood;
124(15): 2400-7, 2014 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25145343
19.
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
Pediatr Blood Cancer;
63(12): 2096-2103, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27511899
20.
Mosaic partial deletion of PTPN12 in a child with interrupted aortic arch type A.
Am J Med Genet A;
167A(11): 2674-83, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26250342